What Are The Chances Of Zomedica Corp. (ZOM) Being A Good Investment?
Zomedica Corp. (AMEX:ZOM) has a beta value of 0.33 and has seen 30.1 million shares traded in the last trading session. The company, currently valued at $914.04M, closed the last trade at $0.95 per share which meant it lost $0.0 on the day or -0.08% during that session. The ZOM stock price is -206.32% off its 52-week high price of $2.91 and 93.68% above the 52-week low of $0.06. If we look at the companys 10-day average daily trading volume, we find that it stood at 38.87 million shares traded. The 3-month trading volume is 61.10 million shares. The consensus among analysts is that Zomedica Corp. (ZOM) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. Zomedica Corp. (AMEX:ZOM) trade information  Sporting -0.08% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 06/14/21 when the ZOM stock price touched $0.95 or saw a rise of 6.86%. Year-to-date, Zomedica Corp. shares have moved 310.15%, while the 5-day performance has seen it change -2.16%. Over the past 30 days, the shares of Zomedica Corp. (AMEX:ZOM) have changed 31.32%. Short interest in the company has seen 59.4 million shares shorted with days to cover at 1.9. Wall Street analysts have a consensus price target for the stock at $1.20, which means that the shares value could jump 20.83% from current levels. The projected low price target is $1.20 while the price target rests at a high of $1.20. In that case, then, we find that the current price level is -26.32% off the targeted high while a plunge would see the stock gain -26.32% from current levels. Zomedica Corp. (ZOM) estimates and forecasts  The companys shares have gained 489.65% over the past 6 months, compared to 4.90% for the industry. 1 have an estimated revenue figure of $1.1 million for the next quarter concluding in Jun 2021. If we evaluate the companys growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 8.90% over the past 5 years. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Add them to your watchlist before they take off! Get the Top 5 Stocks Now! Sponsored  ZOM Dividends  Zomedica Corp. is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the companys debt issue. Zomedica Corp. (AMEX:ZOM)s Major holders  Insiders own 2.58% of the company shares, while shares held by institutions stand at 12.25% with a share float percentage of 12.58%. Investors are also buoyed by the number of investors in a company, with Zomedica Corp. having a total of 109 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 40.78 million shares worth more than $64.43 million. As of Mar 30, 2021, Vanguard Group, Inc. (The) held 37.74% of shares outstanding. The other major institutional holder is Blackrock Inc., with the holding of over 17.17 million shares as of Mar 30, 2021. The firms total holdings are worth over $27.13 million and represent 15.89% of shares outstanding. Also the top two Mutual Funds that are holding companys shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 23.49% shares in the company for having 25.38 million shares of worth $40.1 million while later fund manager owns 13.36 million shares of worth $21.11 million as of Mar 30, 2021, which makes it owner of about 12.37% of companys outstanding stock.